Mirador Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $250M

  • Investors
  • 17

Mirador Therapeutics General Information

Description

Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. The company offers features such as a proprietary data analytics engine that harmonizes extensive patient molecular profiles, identifies novel therapeutic targets, and develops diagnostics, enabling researchers and healthcare providers to create targeted therapies based on individual genetics, ultimately improving treatment outcomes for patients suffering from chronic conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4902 Headquarters Point
  • Suite 300
  • San Diego, CA 92121
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Corporate Office
  • 4902 Headquarters Point
  • Suite 300
  • San Diego, CA 92121
  • United States

Mirador Therapeutics Timeline

20252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirador Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 30-Sep-2025 $250M Completed Generating Revenue
2. Early Stage VC (Series A) 21-Mar-2024 Completed Generating Revenue
1. Seed Round $85M $85M Completed Generating Revenue
To view Mirador Therapeutics’s complete valuation and funding history, request access »

Mirador Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
Seed 34,000,000 $0.000100 $2.5 $2.5 1x $2.5 11.22%
To view Mirador Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Mirador Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory disease
Biotechnology
San Diego, CA

Morrisville, NC
 

Allschwil, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mirador Therapeutics Competitors (17)

One of Mirador Therapeutics’s 17 competitors is Kriya Therapeutics, a Venture Capital-Backed company based in Morrisville, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kriya Therapeutics Venture Capital-Backed Morrisville, NC
Bright Peak Therapeutics Venture Capital-Backed Allschwil, Switzerland
PrecisionLife Venture Capital-Backed Oxford, United Kingdom
Fibrocor Therapeutics Venture Capital-Backed Toronto, Canada
Aulos Venture Capital-Backed Larkspur, CA
You’re viewing 5 of 17 competitors. Get the full list »

Mirador Therapeutics Patents

Mirador Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026136516-A2 Osmr-binding antibodies Pending 19-Dec-2024
WO-2026136516-A3 Osmr-binding antibodies Pending 19-Dec-2024
WO-2026060117-A1 Bispecific antibodies binding to tl1a and osmr Pending 13-Sep-2024
WO-2026011090-A1 Methods, compositions, and kits for treatment of inflammatory diseases by targeting ripk2 Pending 03-Jul-2024
US-20260091026-A1 Methods of treating inflammatory diseases Pending 09-Jun-2023 A61K31/437
To view Mirador Therapeutics’s complete patent history, request access »

Mirador Therapeutics Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
ARCH Venture Partners Venture Capital Minority
Blue Owl Capital Asset Manager Minority
Boxer Capital Corporate Venture Capital Minority
Fairmount Partners Investment Bank Minority
You’re viewing 5 of 17 investors. Get the full list »

Mirador Therapeutics Investments (1)

Mirador Therapeutics’s most recent deal was a PIPE with Jasper Therapeutics for . The deal was made on 16-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Jasper Therapeutics 16-Jul-2026 PIPE Biotechnology
To view Mirador Therapeutics’s complete investments history, request access »

Mirador Therapeutics FAQs

  • When was Mirador Therapeutics founded?

    Mirador Therapeutics was founded in 2024.

  • Where is Mirador Therapeutics headquartered?

    Mirador Therapeutics is headquartered in San Diego, CA.

  • What industry is Mirador Therapeutics in?

    Mirador Therapeutics’s primary industry is Biotechnology.

  • Is Mirador Therapeutics a private or public company?

    Mirador Therapeutics is a Private company.

  • What is the current valuation of Mirador Therapeutics?

    The current valuation of Mirador Therapeutics is .

  • What is Mirador Therapeutics’s current revenue?

    The current revenue for Mirador Therapeutics is .

  • How much funding has Mirador Therapeutics raised over time?

    Mirador Therapeutics has raised $735M.

  • Who are Mirador Therapeutics’s investors?

    Alexandria Venture Investments, ARCH Venture Partners, Blue Owl Capital, Boxer Capital, and Fairmount Partners are 5 of 17 investors who have invested in Mirador Therapeutics.

  • Who are Mirador Therapeutics’s competitors?

    Kriya Therapeutics, Bright Peak Therapeutics, PrecisionLife, Fibrocor Therapeutics, and Aulos are some of the 17 competitors of Mirador Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process